Literature DB >> 11304473

Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma.

M Inoue1, H Itoh, T Tanaka, T H Chun, K Doi, Y Fukunaga, N Sawada, J Yamshita, K Masatsugu, T Saito, S Sakaguchi, M Sone, T Yurugi, K Nakao.   

Abstract

Vascular endothelial growth factor (VEGF) has been recognized as an angiogenic factor that induces endothelial proliferation and vascular permeability. Recent studies have also suggested that VEGF can promote macrophage migration, which is critical for atherosclerosis. We have reported that VEGF is remarkably expressed in activated macrophages, endothelial cells, and smooth muscle cells within human coronary atherosclerotic lesions, and we have proposed the significance of VEGF in the progression of atherosclerosis. To clarify the mechanism of VEGF expression in atherosclerotic lesions, we examined the regulation of VEGF expression by oxidized low density lipoprotein (Ox-LDL), which is abundant in atherosclerotic arterial walls. A recent report has revealed that peroxisome proliferator-activated receptor-gamma (PPARgamma) is expressed not only in adipocytes but also in monocytes/macrophages and has suggested that PPARgamma may have a role in the differentiation of monocytes/macrophages. Furthermore, 9- and 13-hydroxy-(S)-10,12-octadecadienoic acid (9- and 13-HODE, respectively), the components of Ox-LDL, may be PPARgamma ligands. Therefore, we investigated the involvement of PPARgamma in the regulation of VEGF by Ox-LDL. PPARgamma expression was detected in human monocyte/macrophage cell lines, human acute monocytic leukemia (THP-1) cells, and human coronary artery endothelial cells (HCAECs). Ox-LDL (10 to 50 microg/mL) upregulated VEGF secretion from THP-1 dose-dependently. VEGF mRNA expression in HCAECs was also upregulated by Ox-LDL. The mRNA expression of VEGF in THP-1 cells and HCAECs was also augmented by PPARgamma activators, troglitazone (TRO), and 15-deoxy-(12,14)-prostaglandin J(2) (PGJ2). In contrast, VEGF expression in another monocyte/macrophage cell line, human histiocytic lymphoma cells (U937), which lacks PPARgamma expression, was not augmented by TRO or PGJ2. We established the U937 cell line, which permanently expresses PPARgamma (U937T). TRO and Ox-LDL augmented VEGF expression in U937T. In addition, VEGF production by THP-1 cells was significantly increased by exposure to 9-HODE and 13-HODE. In conclusion, Ox-LDL upregulates VEGF expression in macrophages and endothelial cells, at least in part, through the activation of PPARgamma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304473     DOI: 10.1161/01.atv.21.4.560

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  30 in total

1.  Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion.

Authors:  Jana Barlic; Wenjia Zhu; Philip M Murphy
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 2.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 3.  PPAR-γ -- a possible drug target for complicated pregnancies.

Authors:  Fergus P McCarthy; Aoife C Delany; Louise C Kenny; Sarah K Walsh
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

4.  Hydroxyoctadecadienoic acids regulate apoptosis in human THP-1 cells in a PPARγ-dependent manner.

Authors:  Venkat N Vangaveti; Venkatesh M Shashidhar; Catherine Rush; Usman H Malabu; Roy R Rasalam; Fiona Collier; Bernhard T Baune; Richard L Kennedy
Journal:  Lipids       Date:  2014-10-21       Impact factor: 1.880

5.  Oxidized low-density lipoprotein decreases VEGFR2 expression in HUVECs and impairs angiogenesis.

Authors:  Min Zhang; Li Jiang
Journal:  Exp Ther Med       Date:  2016-10-19       Impact factor: 2.447

6.  Placental growth factor levels in quadriceps muscle are reduced by a Western diet in association with advanced glycation end products.

Authors:  Asitha T Silva; Farzana Rouf; Oluwayemisi A Semola; Mark E Payton; Pamela C Lovern
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-09       Impact factor: 4.733

7.  Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease.

Authors:  Mehmet Akif Oztürk; Selman Unverdi; Suna O Oktar; Neslihan Bukan; Ozlem Gülbahar; Kemal Ureten; Berna Göker; Seminur Haznedaroglu; Gülten Sungur; Tansu Ulukavak Ciftçi; A Mesut Onat
Journal:  Clin Rheumatol       Date:  2008-01-18       Impact factor: 2.980

8.  Circulating levels of lectin-like oxidized low-density lipoprotein receptor-1 are associated with inflammatory markers.

Authors:  Valter Lubrano; Serena Del Turco; Giuseppina Nicolini; Pietro Di Cecco; Giuseppina Basta
Journal:  Lipids       Date:  2008-09-10       Impact factor: 1.880

9.  PPARδ agonist GW501516 prevents uncoupling of endothelial nitric oxide synthase in cerebral microvessels of hph-1 mice.

Authors:  Anantha Vijay R Santhanam; Livius V d'Uscio; Tongrong He; Zvonimir S Katusic
Journal:  Brain Res       Date:  2012-09-13       Impact factor: 3.252

10.  Pathogenesis of atherosclerosis: A multifactorial process.

Authors:  Raja B Singh; Sushma A Mengi; Yan-Jun Xu; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.